(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BDH2 mRNA] CTD PMID:31150632 1,1-dichloroethene decreases expression ISO RGD:1320492 6480464 vinylidene chloride results in decreased expression of BDH2 mRNA CTD PMID:26682919 17beta-estradiol decreases expression ISO RGD:1604606 6480464 Estradiol results in decreased expression of BDH2 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1604606 6480464 Tetrachlorodibenzodioxin affects the expression of BDH2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320492 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BDH2 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320492 6480464 Tetrachlorodibenzodioxin results in decreased expression of BDH2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BDH2 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BDH2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of BDH2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1604606 6480464 Lactic Acid results in decreased expression of BDH2 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604606 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BDH2 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1320492 6480464 Methylcholanthrene results in decreased expression of BDH2 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1320492 6480464 Fenretinide results in increased expression of BDH2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of BDH2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of BDH2 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1320492 6480464 Aflatoxin B1 results in decreased expression of BDH2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1604606 6480464 Aflatoxin B1 results in decreased methylation of BDH2 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BDH2 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1604606 6480464 Aflatoxin B1 results in decreased expression of BDH2 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1604606 6480464 Tretinoin results in decreased expression of BDH2 mRNA CTD PMID:33167477 arsane affects methylation ISO RGD:1604606 6480464 Arsenic affects the methylation of BDH2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1604606 6480464 Arsenic affects the methylation of BDH2 gene CTD PMID:25304211 arsenous acid multiple interactions ISO RGD:1604606 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BDH2 protein] CTD PMID:26598702 benzo[a]pyrene increases methylation ISO RGD:1604606 6480464 Benzo(a)pyrene results in increased methylation of BDH2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1604606 6480464 Benzo(a)pyrene affects the methylation of BDH2 exon CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1604606 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1320492 6480464 Diethylhexyl Phthalate results in decreased expression of BDH2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1320492 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of BDH2 mRNA] CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BDH2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1320492 6480464 bisphenol A results in increased expression of BDH2 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BDH2 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression ISO RGD:1604606 6480464 bisphenol A affects the expression of BDH2 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1604606 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BDH2 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:1604606 6480464 bisphenol B results in increased expression of BDH2 protein CTD PMID:34186270 butanal decreases expression ISO RGD:1604606 6480464 butyraldehyde results in decreased expression of BDH2 mRNA CTD PMID:26079696 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BDH2 mRNA CTD PMID:25993096 carbon nanotube increases expression ISO RGD:1320492 6480464 Nanotubes, Carbon analog results in increased expression of BDH2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1320492 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BDH2 mRNA CTD PMID:22023808 cisplatin decreases expression ISO RGD:1320492 6480464 Cisplatin results in decreased expression of BDH2 mRNA CTD PMID:35367536 cisplatin multiple interactions ISO RGD:1320492 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of BDH2 mRNA] CTD PMID:35367536 cisplatin increases expression ISO RGD:1604606 6480464 Cisplatin results in increased expression of BDH2 mRNA CTD PMID:27594783 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BDH2 mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO RGD:1604606 6480464 Copper Sulfate results in decreased expression of BDH2 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of BDH2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1604606 6480464 Cyclosporine results in decreased expression of BDH2 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1604606 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BDH2 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:1604606 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BDH2 protein] CTD PMID:26598702 dicrotophos decreases expression ISO RGD:1604606 6480464 dicrotophos results in decreased expression of BDH2 mRNA CTD PMID:28302478 doxorubicin decreases expression ISO RGD:1604606 6480464 Doxorubicin results in decreased expression of BDH2 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:1604606 6480464 Selenium results in decreased expression of BDH2 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BDH2 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:1320492 6480464 epoxiconazole results in increased expression of BDH2 mRNA CTD PMID:35436446 ethyl methanesulfonate increases expression ISO RGD:1604606 6480464 Ethyl Methanesulfonate results in increased expression of BDH2 mRNA CTD PMID:23649840 ferric oxide increases expression ISO RGD:1320492 6480464 ferric oxide analog results in increased expression of BDH2 mRNA CTD PMID:25086211 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BDH2 mRNA CTD PMID:33387578 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of BDH2 mRNA CTD PMID:20621112 hydrogen peroxide affects expression ISO RGD:1604606 6480464 Hydrogen Peroxide affects the expression of BDH2 mRNA CTD PMID:20044591 hydroquinone decreases expression ISO RGD:1604606 6480464 hydroquinone results in decreased expression of BDH2 mRNA CTD PMID:31256213 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of BDH2 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1604606 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BDH2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1604606 6480464 Ivermectin results in decreased expression of BDH2 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:1320492 6480464 lead acetate results in increased expression of BDH2 mRNA CTD PMID:20542052 melatonin multiple interactions ISO RGD:1320492 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of BDH2 mRNA] CTD PMID:35367536 menadione affects expression ISO RGD:1604606 6480464 Vitamin K 3 affects the expression of BDH2 mRNA CTD PMID:20044591 methyl methanesulfonate increases expression ISO RGD:1604606 6480464 Methyl Methanesulfonate results in increased expression of BDH2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1604606 6480464 methylmercuric chloride results in decreased expression of BDH2 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BDH2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BDH2 mRNA CTD PMID:17602206 N-nitrosodiethylamine decreases expression ISO RGD:1320492 6480464 Diethylnitrosamine results in decreased expression of BDH2 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:1320492 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BDH2 mRNA CTD PMID:24535843 NAD zwitterion multiple interactions ISO RGD:1604606 6480464 NAD binds to and results in increased activity of BDH2 protein CTD PMID:25526675 NAD(+) multiple interactions ISO RGD:1604606 6480464 NAD binds to and results in increased activity of BDH2 protein CTD PMID:25526675 nickel atom decreases expression ISO RGD:1604606 6480464 Nickel results in decreased expression of BDH2 mRNA CTD PMID:24768652 , PMID:25583101 ochratoxin A increases expression ISO RGD:1604606 6480464 ochratoxin A results in increased expression of BDH2 mRNA CTD PMID:30559759 oxaliplatin increases expression ISO RGD:1604606 6480464 oxaliplatin results in increased expression of BDH2 mRNA CTD PMID:16510598 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of BDH2 mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:1320492 6480464 Acetaminophen affects the expression of BDH2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BDH2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1604606 6480464 Acetaminophen results in decreased expression of BDH2 mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BDH2 mRNA CTD PMID:32680482 perfluorobutanesulfonic acid increases expression ISO RGD:1604606 6480464 perfluorobutanesulfonic acid results in increased expression of BDH2 mRNA CTD PMID:35337807 perfluorodecanoic acid increases expression ISO RGD:1604606 6480464 perfluorodecanoic acid results in increased expression of BDH2 mRNA CTD PMID:35337807 perfluorododecanoic acid decreases expression ISO RGD:1604606 6480464 perfluorododecanoic acid results in decreased expression of BDH2 mRNA CTD PMID:35337807 perfluoroheptanoic acid increases expression ISO RGD:1604606 6480464 perfluoro-n-heptanoic acid results in increased expression of BDH2 mRNA CTD PMID:35337807 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1604606 6480464 perfluorooctane sulfonic acid results in increased expression of BDH2 mRNA CTD PMID:35337807 perfluorooctanesulfonamide increases expression ISO RGD:1604606 6480464 perfluorooctanesulfonamide analog results in increased expression of BDH2 mRNA CTD PMID:35337807 perfluorooctanoic acid multiple interactions ISO RGD:1320492 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of BDH2 mRNA] CTD PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:1320492 6480464 perfluorooctanoic acid results in decreased expression of BDH2 mRNA CTD PMID:23626681 perfluoroundecanoic acid increases expression ISO RGD:1604606 6480464 perfluoroundecanoic acid results in increased expression of BDH2 mRNA CTD PMID:35337807 phenobarbital decreases expression ISO RGD:1320492 6480464 Phenobarbital results in decreased expression of BDH2 mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO RGD:1320492 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BDH2 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of BDH2 mRNA] CTD PMID:19482888 , PMID:24535843 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of BDH2 mRNA CTD PMID:18158353 pirinixic acid multiple interactions ISO RGD:1320492 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of BDH2 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:1320492 6480464 pirinixic acid results in decreased expression of BDH2 mRNA CTD PMID:20813756 , PMID:23811191 progesterone increases expression ISO RGD:1320492 6480464 Progesterone results in increased expression of BDH2 mRNA CTD PMID:22238285 quercetin decreases expression ISO RGD:1604606 6480464 Quercetin results in decreased expression of BDH2 mRNA CTD PMID:21632981 quercetin decreases expression ISO RGD:1320492 6480464 Quercetin results in decreased expression of BDH2 mRNA CTD PMID:25862958 rac-lactic acid decreases expression ISO RGD:1604606 6480464 Lactic Acid results in decreased expression of BDH2 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BDH2 mRNA CTD PMID:28374803 selenium atom decreases expression ISO RGD:1604606 6480464 Selenium results in decreased expression of BDH2 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1604606 6480464 Silicon Dioxide analog results in decreased expression of BDH2 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1320492 6480464 Silver results in decreased expression of BDH2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1320492 6480464 Silver results in decreased expression of BDH2 mRNA CTD PMID:27131904 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BDH2 protein CTD PMID:29459688 sunitinib decreases expression ISO RGD:1604606 6480464 Sunitinib results in decreased expression of BDH2 mRNA CTD PMID:31533062 tetrachloromethane decreases expression ISO RGD:1320492 6480464 Carbon Tetrachloride results in decreased expression of BDH2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BDH2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BDH2 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BDH2 mRNA CTD PMID:23411599 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BDH2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1320492 6480464 titanium dioxide results in decreased expression of BDH2 mRNA CTD PMID:29264374 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of BDH2 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:1320492 6480464 triptolide results in decreased expression of BDH2 mRNA CTD PMID:32835833 triptonide decreases expression ISO RGD:1320492 6480464 triptonide results in decreased expression of BDH2 mRNA CTD PMID:33045310 trovafloxacin increases expression ISO RGD:1320492 6480464 trovafloxacin results in increased expression of BDH2 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1604606 6480464 Urethane results in decreased expression of BDH2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1320492 6480464 Valproic Acid affects the expression of BDH2 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1604606 6480464 Valproic Acid results in increased expression of BDH2 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid decreases methylation ISO RGD:1604606 6480464 Valproic Acid results in decreased methylation of BDH2 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1604606 6480464 Valproic Acid affects the expression of BDH2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1604606 6480464 Valproic Acid results in decreased expression of BDH2 mRNA CTD PMID:23179753 , PMID:28001369 vancomycin increases expression ISO RGD:1320492 6480464 Vancomycin results in increased expression of BDH2 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of BDH2 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1604606 6480464 vorinostat results in increased expression of BDH2 mRNA CTD PMID:27188386